USX:XOMAP - XOMA Corporation XOMA Corporation
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 26.15    +0.018 (+0.07%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

30 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Mr. James R. Neal

IPO: 2020-12-16

Headquarters: US

Employees: 10

Homepage

Description

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. The company has an extensive and growing portfolio with more than 70 assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate).